Computational Inference
Prioritizes promising molecular directions early to reduce time spent on low-value pathways.
Precision chemistry for safer medicines
Rapid iterative development powered by computational modeling, rational design, and tissue-selective delivery strategies.
Our discovery strategy starts with patient need, then aligns chemistry, modeling, and early development planning to move meaningful ideas forward with purpose.
SynthIND combines advanced computation, molecular modeling, and practical medicinal chemistry workflows to accelerate the path from concept to candidate.
Prioritizes promising molecular directions early to reduce time spent on low-value pathways.
Physics-aware simulation at atomic resolution to improve selectivity and target fit.
Structure-guided iteration to balance potency, safety profile, and developability.
Targeted delivery approaches intended to improve therapeutic effect and reduce off-target burden.
Founded by a physician, medicinal chemist, and translational scientist, SynthIND brings a translational science lens to discovery by balancing real patient needs with rigorous early planning.
Investors • Partners • Collaborators • Talent